Prof. Abdul Badi Abou Samra, 
Director of Qatar Metabolic Institute & Chief Quality Officer -HMC

Professor Abdul-Badi Abou-Samra is MD, PhD physician scientist, with extensive research history at several international institutions which include Lyon I University, France (5 years), the National Institute of Health, Bethesda, Maryland (2 years), Harvard Medical School and the Massachusetts General Hospital (21 years), and the Wayne State University School of Medicine (5 years).  His last appointment prior to joining HMC was Chief of Endocrinology, Diabetes and Metabolic Diseases and Director of the clinical endocrine fellowship program at Wayne State University, Detroit, Michigan.

Dr. Abou-Samra received multiple recognitions for his scientific contributions and led several research projects funded by the National Institutes of Health. He is known for his molecular and clinical research on G protein-coupled receptors, insulin action and nutritionally-regulated genes.  Dr. Abou-Samra published over 140 original papers in peer-reviewed journals and contributed to 5 USA patents. He was member of the endocrine NIH study section and member of editorial board for several international journals. 

In January 2013 Dr. Abou-Samra joined Hamad Medical Corporation in Doha, Qatar, as the Chairman of the Department of Internal Medicine and Professor of Medicine at Weil Cornell Medical College - Qatar.  Professor Abou-Samra is Co-Chair for the Qatar National Diabetes Committee with the mandate of developing a national strategy for diabetes in Qatar and Chairman for the Qatar Metabolic Institute.